This inventor holds 1 USPTO granted patent. Top assignee: Ethypharm, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jack Zerrouk: Innovator in Opioid Tablet Technology
Introduction
Jack Zerrouk is a notable inventor based in Rouen, France. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative opioid formulations. His work focuses on creating effective and safer medication options for patients.
Latest Patents
Zerrouk holds a patent for a low-dosage orodispersible opioid tablet. This invention includes 10 to 30% by weight of opioid granules and 70% to 90% by weight of a mixture of compression excipients. The granules consist of 8 to 27% by weight of the opioid and 72% to 93% by weight of a mixture of diluent and binder. The mixture of compression excipients contains at least one disintegrating agent, one diluting agent, one lubricating agent, and one permeabilizing agent. Additionally, the patent outlines a method for preparing the tablet, ensuring a precise formulation for optimal efficacy.
Career Highlights
Jack Zerrouk is currently associated with Ethypharm, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in opioid formulations has positioned him as a key player in the industry, contributing to advancements in medication delivery systems.
Collaborations
Zerrouk collaborates with fellow inventor Bruno Criere, working together to enhance the development of pharmaceutical products. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Jack Zerrouk's contributions to opioid tablet technology reflect his commitment to improving patient care through innovative solutions. His patent for a low-dosage orodispersible opioid tablet showcases his expertise and dedication to the field.